Literature DB >> 2920210

High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia.

A Lindemann1, W D Ludwig, W Oster, R Mertelsmann, F Herrmann.   

Abstract

Hairy cell leukemia (HCL) is frequently associated with severe pancytopenia. The authors detected high levels of tumor necrosis factor (TNF)-alpha in the bone marrow serum of patients with HCL and found anti-TNF-alpha neutralizing monoclonal antibodies (MoAbs) to be able to enhance hematopoiesis of HCL patients in in vitro colony assays. As potent producers of TNF-alpha, hairy cells could be identified, thus implicating the malignant population in the pathogenesis of hematopoietic failure due to inappropriate secretion of this cytokine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920210

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters.

Authors:  D M Nachbaur; M Herold; A Maneschg; H Huber
Journal:  Ann Hematol       Date:  1991 Feb-Mar       Impact factor: 3.673

Review 2.  Regulation of tumor necrosis factor production by monocyte-macrophages and lymphocytes.

Authors:  G Trinchieri
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Gene expression of cytokines suppressing hematopoietic progenitor cells in lymphoid malignancies.

Authors:  C Kawasaki; S Okamura; S Hayashi; S Kondo; M Harada; Y Niho
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Interleukin-2 and interferon-gamma recruit different subsets of human peripheral blood monocytes to secrete interleukin-1 beta and tumour necrosis factor-alpha.

Authors:  F Herrmann; G Gebauer; A Lindemann; M Brach; R Mertelsmann
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

5.  Loss of SIMPL compromises TNF-alpha-dependent survival of hematopoietic progenitors.

Authors:  Eric A Benson; Mark G Goebl; Feng-Chun Yang; Reuben Kapur; Jeanette McClintick; Sonal Sanghani; D Wade Clapp; Maureen A Harrington
Journal:  Exp Hematol       Date:  2009-11-23       Impact factor: 3.084

6.  Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.

Authors:  B Barut; D Chauhan; H Uchiyama; K C Anderson
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Authors:  M Nagel-Hiemke; C Hiemke; G Kummer; T Moritz; H Müller; S Seeber; N Niederle
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

8.  Tumor necrosis factor alpha production in schistosomiasis with carcinoma of urinary bladder.

Authors:  S Raziuddin; M Masihuzzaman; S Shetty; A Ibrahim
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

9.  Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer.

Authors:  R Morant; F Stiefel; W Berchtold; A Radziwill; W Riesen
Journal:  Support Care Cancer       Date:  1993-03       Impact factor: 3.603

Review 10.  Cytokines in the pathophysiology and treatment of chronic B-cell malignancies. A review.

Authors:  M Schuler; C Huber; C Peschel
Journal:  Ann Hematol       Date:  1995-08       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.